𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of BCR-ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR-related sequence in human DNA

✍ Scribed by Christophe Marcelle; Robert P. Gale; Miron Prokocimer; Alan Berrebi; Hélène Merle-Beral; Dr. Eli Canaani

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
674 KB
Volume
1
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

The Philadelphia chromosome is present in more than 95% of chronic myelogenous leukemia patients and in up to 25% of patients with acute lymphocytic leukemia. The major consequence of the aberration is the fusion of the ABL and BCR genes. The position of the breakpoint on chromosome 22 determines which species of the potential three fused mRNAs and proteins will be synthesized. We have used the polymerase chain reaction (PCR) to detect these mRNAs in 53 patients and cell lines and found that around 20% contain simultaneously two BCR-ABL mRNAs, presumably due to a process of alternative splicing. The results also indicate that most patients in lymphocytic blast crisis of CML contain the mRNA in which bcr exon 2 is linked to ABL exon II. Finally, we identified, cloned, and characterized a BCR-related sequence that originated from mRNA.

📜 SIMILAR VOLUMES

Absence of the hybrid bcr-abl mRNA in Ph
Absence of the hybrid bcr-abl mRNA in Ph1-positive B lymphoblastoid cell lines established from a patient with chronic myelogenous leukemia
✍ Toshiyuki Yamada; Tsuneyuki Oikawa; Noboru Kuzumaki; Nobuo Takagi; Motomichi Sas 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

The expression of c-abl, c-sis, c-myc and N-ras oncogenes was examined in 2 lymphoblastoid cell lines, one with Ph1 (PB-1049) and the other without Ph1 (LN-1049), both established from a patient with chronic myelogenous leukemia (CML), and in a Ph1-positive cell line (PB-1049-T) derived from a tumor

Applicability of an absolute quantitativ
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients
✍ Karl-Anton Kreuzer; Ulrich Lass; Stefan Nagel; Heinz Ellerbrok; Georg Pauli; Bär 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 149 KB

Chimeric bcr/abl fusion proteins are thought to be the molecular 'pathogen' of chronic myelogenous leukaemia (CML). Expression levels of the respective fusion RNAs reflect disease progression as well as remission upon therapeutic intervention in CML patients. However, there is no quick and reliable

O37 BCR-ABL kinase domain mutations and
O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia
✍ H. Andrikovics; N. Meggyesi; S. Lueff; A. Batai; E. Adam; A. Kozma; G. Halm; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Hb-Hana family is the first described example, where partial glutathione reductase deficiency represents a modifying factor of clinical manifestation of unstable hemoglobinopathy. Grant support: MSM 6198959205 and MSM 6198959216. O35 A prognostic impact of transfusion dependency on survival of pati

Translocation of BCR to chromosome 9: A
Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia
✍ Dr. Anne Hagemeijer; Arjan Buijs; Elizabeth Smit; Bart Janssen; Geert-Jan Creeme 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract Leukemic cells from two patients with Philadelphia‐negative chronic myeloid leukemia (CML) were investigated: I) Cytogenetics showed a normal 46.XY karyotype in both cases, 2) molecular studies revealed rearrangement of the M‐BCR region and formation of __BCR‐ABL__ fusion mRNA with b2a2